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Stearoyl-CoA desaturase (SCD) is a key enzyme that determines the composition and metabolic fate of ingested fatty acids, in particular the con-
version of trans-vaccenic acid (TVA) to conjugated linoleic acid (CLA). The present study addressed the hypothesis that intestinal TVA absorption
and biotransformation into CLA can be modulated by EPA and 3,10-dithia stearic acid (DSA) via altered SCD mRNA levels and desaturation
indices (cis-9, trans-11-CLA:TVA and oleic acid:stearic acid ratios) in Caco-2 and T84 cells, two well-established in vitro models of the
human intestinal epithelium. The study determined the effect of acute (3 h with 0·3 mM-EPA or 0·3 mM-DSA) and acute-on-chronic (1 week
with 0·03 mM-EPA or -DSA, followed by respectively, 0·3 mM-EPA or -DSA for 3 h) treatments. In both cell lines, acute EPA treatment did
not alter SCD desaturation indices, whereas the acute-on-chronic treatment affected these surrogate markers of SCD activity. This was associated
with reduced sterol regulatory-element binding protein-1c and SCD mRNA levels. In contrast, acute and acute-on-chronic DSA treatments signifi-
cantly reduced SCD desaturation indices without affecting SCD mRNA levels in Caco-2 cells. The present study on intestinal cells shows that the
conversion rate of TVA to c9, t11-CLA is affected by other fatty acids present in the diet such as EPA, confirming previous observations in hepatic
and mammary cell models.
Stearoyl-CoA desaturase: Trans fatty acids: Conjugated linoleic acid
Trans-vaccenic acid (TVA; trans-11-18: 1) is a natural trans
fatty acid, found in foods derived from ruminant animals,
in particular dairy products, and is formed through biohydro-
genation of unsaturated fatty acids by ruminal bacteria
(Sommerfeld, 1983; Slattery et al. 2001). TVA is believed
to have potential positive effects on health due to its partial
metabolic conversion to rumenic acid, the well-known cis-9,
trans-11-conjugated linoleic acid (c9, t11-CLA) (Lock et al.
2004). Since TVA is the precursor of CLA, it is important
to understand whether its intestinal absorption and metabolism
can be modulated by other nutrients (Lin et al. 2004), thus
affecting the bio-potency of CLA.
The enzyme responsible for the conversion of TVA to c9,
t11-CLA is stearoyl-CoA desaturase (SCD). SCD classically
converts stearoyl-CoA into oleoyl-CoA. This enzyme
has been studied for a long time, due to this crucial role in
regulating the unsaturated:saturated ratio, which in turn
influences many cellular functions including the fluidity of
the cell membranes (Kim & Ntambi, 1999). SCD is strongly
modulated by nutrients, drugs, environmental factors (for a
review, see Ntambi & Miyazaki, 2004). To our knowledge,
from all substances known to act on the D-9 desaturation pro-
cess, only sterculic acid (Lock et al. 2004) has been studied
for its effects on the conversion of TVA to c9, t11-CLA.
Nutrients, in particular fatty acids, regulate SCD both at the
transcription and enzyme activity levels. The half-life of the
SCD mRNA can be shortened by the PUFA arachidonic
acid (Sessler et al. 1996). The amount of SCD mRNA can
also be regulated by several transcription factors, including
sterol regulatory-element binding protein-1c (SREBP-1c) and
PPARa. So far, SCD is the only gene identified to be under
the control of both factors (Nakamura & Nara, 2002), which
is unusual since SREBP-1c regulates lipid synthesis and
PPARa lipid oxidation.
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The present study investigated the effect of EPA and
3,10-dithia stearic acid (DSA) on SCD mRNA levels and
intestinal TVA metabolism in two well characterised polarised
cell culture systems, Caco-2 and T84 cells, models of the lipid
metabolism in human intestinal epithelial cells (Black et al.
2002b). EPA, a natural n-3 PUFA, is a well-known inhibitor
of SCD (Ntambi, 1999). DSA is a fatty acid analogue with
sulfur atoms substituting methylene groups in the carbon
chain at the third and tenth positions. DSA has been used
as SCD inhibitor in 7800 CI Morris hepatoma cells and rat
hepatocytes (Hovik et al. 1997). To date, little is known of
the mechanism whereby fatty acid inhibitors of SCD modulate
TVA metabolism in the gut, which is relevant within the
context of TVA and CLA bioavailability, as well as intestinal
lipid metabolism. Therefore, the objective of the present study
was to understand the interactions between acute (3 h) and
acute-on-chronic (3 h following 7 d fatty acid pre-treatment)
effects of the natural fatty acid EPA v. the sulfur-modified
fatty acid DSA on SCD mRNA abundance and TVA
metabolism.
Materials and methods
Cell culture
Several experiments have investigated TVA metabolism in
hepatic (Gruffat et al. 2005) and mammary (Loor et al.
2002, 2003; Lin et al. 2004) cells but little is know of its
effect in intestinal cells. The intestine is the first organ to be
exposed to and metabolise fatty acids; there, fatty acids are
metabolised and incorporated into chylomicrons. It plays a
key role in determining the exposure of other organs to dietary
fatty acids (Black et al. 2002a,b). Therefore, the epithelial cell
lines Caco-2 and T84 were chosen as in vitro models of intes-
tinal epithelium, to investigate the effect of EPA and DSA on
intestinal TVA metabolism.
The two cell lines were obtained from the European Collec-
tion of Animal Cell Cultures (Salisbury, Wiltshire, UK).
Caco-2 and T84 cells were grown in a 1:1 mixture of
Ham’s F12 and Dulbecco’s modified Eagle’s medium
(Sigma, Poole, Dorset, UK), which was supplemented with
L-glutamine (2 mM; Sigma), penicillin (100 U/ml; Sigma),
streptomycin (100 mg/ml; Sigma) and 10 % fetal calf serum
(GibcoBRL, Paisley, UK). They were incubated in flasks at
378C in a humidified atmosphere of 5 % CO2 and split using
a trypsin–EDTA solution (Sigma). Cells were seeded at a den-
sity of 3 £ 105 cells per 24 mm polycarbonate transwell
(growth area 4·7 cm2; pore size 0·4mm; Costar, High
Wycombe, Bucks, UK) and grown for 14 d. Apical and baso-
lateral media were changed once per d during the course of
cell growth and development. Cell passages used were
between 51 and 52 for Caco-2 cells and between 48 and 49
for T84 cells.
Experimental design
The present study was designed to determine the acute (3 h)
and acute-on-chronic (3 h following 7 d fatty acid pre-treat-
ment) effects of EPA and DSA on TVA metabolism. For
clarity, treatment refers to acute effects and supplementation
refers to chronic effects of fatty acids.
The acute effects of EPA and DSA (kindly supplied by Pro-
fessor Spydevold, Oslo, Norway) were determined in Caco-2
and T84 cells that had been grown for 14 d in standard con-
ditions. For the acute treatment, cells were then incubated
for 30 min with 1 mM-taurocholate and 0·3 mM-EPA or DSA,
and finally for 3 h with 1 mM-taurocholate, 0·3 mM-TVA,
0·3 mM-EPA or -DSA before harvesting. These fatty acid con-
centrations were not toxic and were chosen as possibly phys-
iological on the basis of TVA and EPA dietary intake (Wolff,
1995; Astorg et al., 2004). Taurocholate was used in order to
mimic intestinal lumen fatty acids emulsion (Field et al.
2002).
To investigate the acute-on-chronic effect of fatty acid
supplementation on cell TVA metabolism, the cells received,
after 7 d of culture in standard conditions, chronic fatty
acid supplementation (1 mM-taurocholate and 0·03 mM-EPA or
-DSA) for 7d, followed by 3 h acute treatment (1 mM-
taurocholate, 0·3 mM-TVA, 0·3 mM-EPA or -DSA) before
harvesting.
EPA and DSA were stored in ethanol at 2208C. Sodium
taurocholate was added (1 mM) in order to make the fatty
acids soluble in the media. The fatty acid supplements
were added to the apical compartment of the transwells; the
basolateral compartment did not receive fatty acid supplemen-
tation. This was done to mimic the intestinal epithelium
where only the apical surface of enterocytes is exposed to
dietary fats.
Cell viability
The effect of 0·3 or 0·03 mM-EPA, -DSA or -TVA on Caco-2
or T84 cells proliferation was investigated using the Cell Titer
96 Aqueous Non-Radioactive Cell Proliferation Assay and
protocol (Promega, Madison, WI, USA). Briefly, cells receiv-
ing each fatty acid treatment were seeded in ninety-six-well
microtitre plates (Falcon; Becton-Dickinson Labware, Lincoln
Park, NJ, USA) at a density of 105 cells/well and grown
for 24 h. 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)–phenazine
methosulfate solution (20ml) was added to each well and
cells were incubated for 4 h at 378C before absorbance
reading at 490 nm. Results of the MTS proliferation assay of
Caco-2 cells and T84 supplemented with 0·03 or 0·3 mM-
TVA, -EPA or -DSA are presented in Table 1. ANOVA
demonstrated that the treatments used in these experiments
did not affect the proliferation of either cell line.
The transepithelial electrical resistance (TER) of Caco-2
and T84 cells growing in the inserts was measured with the
Endohm apparatus (World Precision Instruments, Sarasota,
FL, USA) at 24 h intervals. TER increased progressively
during approximately 8–10 d until confluence, when cells
formed high-resistance monolayers with stable TER values
of 340 (SEM 93) V/cm2 (n 48) for T84 cells and 179 (SEM
34) V/cm2 (n 48) for Caco-2 cells. In Caco-2 cells, the supple-
mentations with either EPA or DSA had no significant effect
on TER values compared with control cells. TER values of
T84 cells supplemented with 0·03 mM-EPA or -DSA are pre-
sented in Fig. 1. In T84 cells, DSA was associated with a
marked decrease of TER compared with cells supplemented
with EPA or control cells.
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mRNA abundance
Total RNA was extracted from cells using TriZOL reagent and
protocol from Invitrogen (Paisley, UK). The mRNA levels of
SCD, PPARa and SREBP-1c was analysed using Taq-Man
quantitative real-time PCR.
RNA (2mg) was treated with RNase-free DNase to remove
contaminating genomic DNA (DNAase I Amplification Grade;
Invitrogen). After inactivating the DNase by the addition of
1·5ml EDTA (25 mM) and heating at 658C for 10 min, total
RNA was reverse-transcribed for 1 h at 378C followed by
10 min at 708C in a 25ml reaction mixture containing 5ml
RT buffer (50 mM-Tris–HCl, 75 mM-KCl, 3 mM-MgCl2,
10 mM-dithiothreitol), 500 ng random primers, 0·4 mM-
dNTPs, and 300 units Moloney murine leukaemia virus RT
(Promega). Reactions in which Moloney murine leukaemia
virus RT was omitted served as negative controls. As a stan-
dard, five samples were reverse-transcript; these five samples
were pooled after first-strand cDNA synthesis. This standard
was serially diluted 1:2 in DNase–free water to generate a
standard curve for the PCR analysis. Samples were diluted
in diethyl pyrocarbonate–water (Sigma) in order to obtain a
final concentration of 20 ng/ml.
SCD and PPARa mRNA were quantified using Assay-
on-Demand gene expression assays (Applied Biosystems,
Warrington, Cheshire, UK). Oligonucleotide primers and
Taq-Man probe sequences for SREBP-1c were as follows:
forward–50CCATGGATTGCACTTTCGAA30, reverse–50CCA-
GCATAGGGTGGGTCAAA30, and probe–50TATCAACAACC-
AAGACAGTGACTTCCCTGGC30 (as described in Sewter et al.
2002). The Taq-Man probe was labelled at the 50 end with the
reporter dye 6-carboxy-fluorescein and at the 30 end with
the quencher 6-carboxy-tetramethyl-rhodamine. Oligonucleo-
tide primers and Taq-Man probes for the glyceraldehyde-
3-phosphate dehydrogenase, used as internal control, were
purchased from Applied Biosystems. PCR was carried out in
duplicate for each sample on an ABI 7700-sequence detection
system (Applied Biosystems).
Each 25ml reaction mixture contained 2ml first-strand
cDNA, 1X PCR master mix, 1·25ml Assay-on-Demand for
SCD and PPARa or SREBP-1c forward and reverse
(500 nmol/l) and 250 nmol SREBP-1c Taq-Man probe. All
reactions were carried out using the following cycling par-
ameters: 508C for 2 min, 958C for 10 min, followed by forty
cycles of 958C for 15 s and 608C for 1 min.
After PCR, standard curves were constructed from the stan-
dard reactions for each target gene and internal control by
plotting Ct values, i.e. the cycle number at which the fluor-
escence signal exceeds background v. log cDNA input (ng).
The Ct readings for each of the unknown samples were then
used to calculate the amount of either target or internal control
relative to the standard. For each sample, results were normal-
ised by dividing the amount of target by the amount of internal
control. Repeatability of the PCR was examined by measuring
the Ct readings of three samples.
Fatty acid analysis
Cells were washed twice with cold PBS, scraped into 15 ml
tubes, pelleted at 800 g for 5 min before being stored at
2808C. Total cellular lipids were extracted following the
chloroform–methanol (1:1) procedure of Bligh & Dyer
(1959). As acid methylation induces isomerisation of CLA
in a time- and temperature-correlated manner, the base–
acid methylation parameters were optimised as previously
described (Park et al. 2001) to minimise isomerisation of
cis–trans bonds, artefact formation and to ensure that all
fatty acids were methylated. The lipid extracts were dried
under N2, converted to fatty acid methyl esters using 1 ml
0·1 M-KOH–methanol at 708C for 1 h followed by 0·4 ml
1·2 M-HCl–methanol at 708C for 15 min and extracted with
hexane. The fatty acid methyl esters were separated by
GC, conducted with a Thermo Finnigan Trace GC (Inter-
science, Milan, Italy) fitted with a flame ionisation detector
and Chromquest 3.0 integrator (Thermo Finnigan, San Jose,
CA, USA). A Restek RT-2560 (Bellefonte, PA, USA) fused
silica capillary column (100 m £ 0·25 mm internal diameter,
0·2mm film thickness) was used. The oven temperature
was increased at 258C/min from 80 to 1758C, and held for
25 min. The temperature was then increased at 108C/min
to 2058C and held for 4 min. Finally, it was increased at
108C/min to 2258C and held for 20 min. H2 was used as
the carrier gas. The fatty acid methyl esters were identified
Fig. 1. Transepithelial electrical resistance (TER) of T84 cells grown in
media unsupplemented (control; –O–) or supplemented with EPA (–A–) or
3,10-dithia stearic acid (DSA; · · ·X· · ·) (0·03 mM; passage 48; 3 £ 105
cells/transwell). Values are means of six wells per fatty acid supplementation,
with vertical lines representing standard errors of the mean. *Mean value
was significantly different from that of the control supplementation (P,0·05).
Table 1. Effect of trans-vaccenic acid (TVA), eicosapentaenoic acid
and 3,10-dithia stearic acid (DSA) on cellular proliferation in T84 (pas-
sage 48; 105 cells/well) and Caco-2 (passage 51; 100 000 cells/well)
cells*
(Mean values with their standard errors of four wells per fatty acid treat-
ment)
Proliferation (% of control)
T84 Caco-2
Cell line. . . Mean SEM Mean SEM
Control 1·00 0·05 1·00 0·05
TVA (0·03 mM) 0·95 0·07 1·04 0·03
TVA (0·3 mM) 1·06 0·05 1·18 0·02
EPA (0·03 mM) 1·00 0·05 1·04 0·05
EPA (0·3 mM) 1·06 0·02 0·93 0·07
DSA (0·03 mM) 1·01 0·05 1·04 0·05
DSA (0·3 mM) 1·14 0·04 1·03 0·06
* Determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium proliferation assay.
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by comparison with standards (Alltech Inc., Deerfield, IL,
USA and Nu-Chek Prep Inc., Elysian, MN, USA).
Statistical analysis
Fatty acid data were analysed by the general linear model pro-
cedure of SAS (SAS Institute Inc., Cary, NC, USA). ANOVA
was used to identify the effect of treatment and differences
between treatment means were identified using the probability
of difference option of the least significant means command.
Two-way ANOVA was used to test the effect of fatty acid
treatment (control, EPA and DSA), type of treatment (acute
and acute-on-chronic) and their interaction term. Treatment
effects and differences between means were considered sig-
nificant when P,0·05.
Results
Cellular fatty acid composition
The fatty acid composition of Caco-2 cells (Table 2) shows
the most important changes occurred following the acute-on-
chronic rather than the acute fatty acid treatment. Acute-on-
chronic EPA treatment significantly (P,0·05) reduced oleic
acid levels, a product of SCD activity, but acute-on-chronic
DSA treatment did not. Oleic acid was reduced following
acute EPA and DSA treatments, but these changes were not
significant. Both acute and acute-on-chronic EPA treatments
significantly reduced TVA levels (P,0·01) and c9, t11-CLA
levels (P,0·01). Acute and acute-on-chronic DSA treatments
significantly reduced c9, t11-CLA only (P,0·01).
EPA was incorporated in cellular lipids and was elongated
to 22: 5n-3, but was not desaturated into DHA (22: 6n-3), fol-
lowing both acute and acute-on-chronic fatty acid treatments.
Similar fatty acid profiles were observed in T84 cells (results
not shown).
Stearoyl-CoA desaturase desaturation index
In both cell lines, the SCD desaturation index was defined as
the oleic acid:oleic plus stearic acids ratio. The SCD desatura-
tion index was not affected by any acute treatment, but the
acute-on-chronic treatment with EPA, and to a lesser extent
with DSA, reduced the desaturation levels of stearic acid
(Fig. 2(A)). Supplementation of the nutritive media with
EPA also reduced the desaturation of TVA but the acute treat-
ment did not (Fig. 2(B)). Both acute and acute-on-chronic
exposures with DSA reduced SCD desaturation indices. The
effects were similar on both cell lines but, in T84, the desa-
turation of TVA was lower. SCD desaturation of TVA is
quickly inhibited by DSA during the acute treatment, even
after 1 h (results not shown), which suggests that DSA acts
directly on the enzyme. To obtain inhibition of SCD by
EPA, a longer duration was required, which suggests an
effect limited to the transcription level. In both cell lines,
the two-way ANOVA analysis on desaturation indices indi-
cated that fatty acid treatment, type of treatment and their
interaction were highly significant (P,0·01); this illustrates
Table 2. Caco-2 cell fatty acid composition (mmol/g cellular protein) following acute or acute-on-chronic treatment with eicosapentaenoic acid or
3,10-dithia stearic acid (DSA)
(Mean values with their standard errors of three inserts cultured in parallel)
Acute Acute-on-chronic
Control EPA DSA Control EPA DSA
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM
10 : 0 2·50 0·57 2·28 0·16 2·15 0·51 1·97 0·20 2·89 1·37 1·72 0·40
12 : 0 3·10 0·59 2·65 0·42 2·62 0·73 2·49 0·16 2·79 1·21 2·44 0·67
14 : 0 18·63 2·76 16·91 1·45 17·40 3·22 16·75 0·34 16·79 1·28 14·31 3·43
16 : 0 171·67 25·28 139·87 12·80 141·40 17·06 139·08 5·79 138·34 4·16 111·96 13·86
16 : 1t9 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01
16 : 1c9 87·18 13·47 75·56 8·08 72·28 6·86 72·79 3·28 44·65** 3·73 60·37 7·71
17 : 0 1·08 0·10 1·62 0·75 1·95 1·20 0·76 0·13 1·17 0·61 0·87 0·10
18 : 0 142·13 19·05 119·49 8·51 115·18 12·23 115·96 3·09 110·34 3·82 121·64 13·27
18 : 1t9 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01
18 : 1t11 35·76 5·88 15·45* 1·88 28·01 2·55 30·13 1·70 17·46** 0·58 25·88 4·08
18 : 1c9 285·64 41·4 239·06 22·3 224·72 23·7 231·01 10·3 168·12** 9·2 200·27 24·2
18 : 1c11 101·10 14·1 83·98 7·85 81·30 8·82 77·28 2·42 55·83** 4·03 59·11* 7·89
18 : 2 t9t12 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01
18 : 2n-6 15·20 2·79 11·79 1·57 11·34 1·12 13·23 0·31 12·44 1·11 13·30 1·18
20 : 0 5·93 0·54 4·84 0·33 4·60 0·56 5·09 0·41 2·72** 0·41 4·97 0·71
18 : 3n-3 2·67 0·38 2·73 0·20 2·56 0·38 2·36 1·18 4·25 0·23 5·42 1·66
18 : 2c9t11 16·97 2·55 7·68* 0·92 3·53** 0·36 12·15 0·32 4·35** 0·42 4·26** 0·66
18 : 2t10c12 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01 ,0·01
20 : 3n-6 8·38 1·21 6·71 0·43 6·55 0·65 6·41 0·23 5·56 0·37 6·41 0·84
20 : 4n-6 34·80 5·83 21·53 9·68 28·11 2·87 26·01 0·63 24·21 2·18 25·85 2·88
20 : 5n-3 4·76 0·58 90·65** 9·53 4·22 0·25 3·77 0·30 117·79** 11·6 3·61 0·23
22 : 5n-3 13·46 1·76 21·71* 2·09 10·26 1·10 10·21 0·49 76·50** 6·38 10·22 1·68
22 : 6n-3 14·04 2·29 11·32 1·17 11·14 1·11 10·58 0·10 8·97 0·78 10·46 1·24
Mean value was significantly different from that of the control: * P,0·05; ** P,0·01.
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that acute-on-chronic treatment had more profound effects on
fatty acid composition compared with acute treatment alone.
Stearoyl-CoA desaturase mRNA abundance
In both cell lines, the acute EPA and DSA treatments did not
alter SCD mRNA levels ((Fig. 3(A) and Fig. 3(B)). In contrast
acute-on-chronic EPA supplementation induced a marked
decrease in SCD mRNA levels in Caco-2 cells (1·27
(SD 0·23) v. 0·74 (SD 0·05); P,0·05). But acute-on-chronic
DSA supplementation did not. This effect of EPA may explain
the effect observed on the desaturation index following EPA
acute-on-chronic condition as presented in Fig. 2. EPA sup-
plementation also reduced SCD mRNA levels in T84 cells.
In contrast, DSA supplementation significantly increased
SCD mRNA levels in T84 cells.
mRNA levels of stearoyl-CoA desaturase transcription factors:
sterol regulatory-element binding protein-1c and peroxisome
proliferator-activated receptor a
The transcription of SCD is under the control of two transcrip-
tion factors, SREBP-1c and PPARa (Nakamura & Nara,
2002). We investigated whether the mRNA levels of SREBP-
1c or PPARawas altered by acute or acute-on-chronic adminis-
trations of EPA or DSA. In our experiments, the transcription of
SREBP-1c was reduced by the acute-on-chronic fatty acid
interventions (Fig. 3(C)), but the decrease by DSA was lower
than that observed with EPA. No differences in mRNA levels
of PPARa (Fig. 3(D)) were observed for any exposure. Neither
SREBP-1c nor PPARa mRNA levels were altered by acute
treatments with EPA or DSA (results not shown).
Discussion
TVA is the precursor of c9, t11-CLA, a fatty acid that has
been associated with potential anti-carcinogenic, anti-diabetic,
anti-inflammatory and cardioprotective effects (Belury, 2002;
Roche et al. 2002; Toomey et al. 2003; Field & Schley,
2004; McLeod et al. 2004; O’Shea et al. 2004; Wang &
Jones, 2004). We addressed the hypothesis that intestinal
TVA absorption and biotransformation into CLA can be
modulated by other nutrients or xenobiotics. Therefore, the
present study aimed at investigating whether TVA is metab-
olised in differentiated intestinal cells and determined whether
intestinal TVA metabolism can be modified by PUFA.
The enzyme SCD (also referred to as D9-desaturase; EC
1·14·99·5) catalyses the insertion of a cis double bond in
ninth position in the carbon chain of saturated and unsaturated
fatty acids, including TVA. It has been suggested that several
nutrients (PUFA and fructose), drugs (thia fatty acids and ster-
culic acid) and hormones (insulin and leptin) modulate SCD
expression and activity, as reviewed in Ntambi & Miyazaki
(2004). Moreover mouse in vivo studies (Loor et al. 2002,
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Fig. 2. Effect of acute and acute-on-chronic exposures to EPA (B) or 3,10-dithia stearic acid (B) on fatty acid stearoyl-CoA desaturase (SCD) indices in T84
(A and C) and Caco-2 (B and D) cells compared with control (A). Indices are defined as the ratio of SCD product:(SCD product þ substrate). (A and B) Oleic
acid:(oleic acid þ stearic acid); (C and D) cis9, trans11-conjugated linoleic acid (CLA):(cis9, trans11-CLA þ trans-vaccenic acid (TVA)). Values are means of
three different inserts cultured in parallel, with vertical lines representing standard deviations. a,b,c,d Mean values with unlike letters were significantly different
(P,0·05).
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2003; Lin et al. 2004) demonstrated that TVA metabolism can
be modulated by diet composition. The present study focused
on the effect of EPA on SCD mRNA levels and TVA metab-
olism because preliminary work in Caco-2 cells demonstrated
that EPA was the most effective PUFA to reduce SCD desa-
turation indices in Caco-2 cells (B Renaville, YJ Schneider
and Y Larondelle, unpublished results). In addition, the meta-
bolic effects of DSA, a known pharmacological inhibitor of
SCD (Hovik et al. 1997), were investigated in order to act
as a comparison to the natural fatty acid EPA.
In vivo studies demonstrated that desaturation indices do not
always reflect enzyme activity (Archibeque et al. 2005), in
part because ingestion of SCD substrates and products may
vary between diets. Nevertheless, in our in vitro model,
SCD substrate fatty acid supply was constant, therefore desa-
turation products could not be derived from other fatty acid
sources. Hence we propose that the SCD desaturation index
could be ascribed to different SCD activity, albeit a surrogate
marker for SCD activity. Overall the present results showed
that acute EPA and DSA treatments were insufficient to
cause consistent changes in SCD mRNA levels, SCD activity
on oleic acid and alter fatty acid composition, in comparison
with the acute-on-chronic effect of fatty acid interventions.
This is probably related to insufficient time for the fatty
acids to induce important effects, as previously observed
(Black et al. 2002b). Neither acute EPA nor DSA reduced
oleic acid levels and oleic desaturation indices. Acute DSA
treatment significantly reduced CLA levels and desaturation
indices. Whilst acute EPA treatment reduced CLA concen-
tration, it had no effect on the SCD desaturation index, an
effect which may be ascribed to altered TVA absorption.
Acute-on-chronic EPA reduced TVA, oleic and CLA concen-
trations, which were associated with lower SCD desaturation
indices and lower SCD and SREBP-1c mRNA levels. This
discrepancy between acute and acute-on-chronic EPA effects
probably reflects the cumulative effect of fatty acid exposure
over time (Black et al. 2002b). The chronic effect of EPA
on SREBP-1c mRNA levels in Caco-2 cells agrees with pre-
vious work (Field et al. 2002). Since the transcription factor
SREBP-1c regulates SCD gene transcription, we suggest that
the effect of EPA on SCD mRNA levels was mediated by
SREBP-1c. We propose that lowered levels of SREBP-1c
would decrease SCD gene transcription and expression,
which would in turn decrease the SCD activity on TVA.
The effects of DSA were different from those of EPA. Fur-
thermore, DSA had different effects in the two cell lines stu-
died. In Caco-2 cells, acute treatment and acute-on-chronic
supplementation with DSA significantly reduced SCD desa-
turation indices and CLA concentrations, but did not alter
SCD mRNA levels, suggesting that DSA directly acts on
SCD at the protein level, reducing the desaturation of TVA
by competition, as suggested by Hovik et al. (1997). In T84
cells, again both types of treatment significantly reduced
SCD desaturation indices. However, the acute-on-chronic
DSA condition increased SCD mRNA levels in T84 cells.
The differential effect of DSA on transcription and translation
could be related to time-related differences in the expression
and activity of SCD, between the two cell lines used. Other-
wise the thia group in third position of the chain is known
to activate SCD transcription (Madsen et al. 1997), whereas
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Fig. 3. Effect of acute and acute-on-chronic treatment with EPA (B) or 3,10-dithia stearic acid (B) (7 d with 0·03 mM followed by 3 h with 0·3 mM) on stearoyl-CoA
desaturase (SCD) mRNA levels (Ct values normalised on Ct values of GAPDH) in T84 (A) and Caco-2 (B) cells and effect of acute-on-chronic treatment on sterol
regulatory-element binding protein-1c (SREBP-1c) (C) or PPARa (D) mRNA levels in T84 and Caco-2 cells. Values are means of three different inserts cultured in
parallel, with vertical lines representing standard deviations. a,b,c Mean values with unlike letters were significantly different (P,0·05).
Trans-vaccenic acid desaturation 693
the tenth sulfur substitute to methylene is known to inhibit the
activity of SCD (Hovik et al. 1997), which could be related to
the opposite effects of DSA on activity and transcription of
SCD in T84 cells. Acute-on-chronic DSA treatment also
reduced SREBP-1c mRNA levels but this was not associated
with lower SCD mRNA levels. This implies that lower
SREBP-1c mRNA levels were insufficient to alter or were
not correlated with transcriptional activity. PPARa is a key
transcription factor that regulates fatty acid oxidation,
especially in the liver. Given the regulatory relationship
between SCD and PPARa, we determined whether alterations
in SCD mRNA levels could be explained by differential intes-
tinal PPARa mRNA levels. In the present study, neither EPA
nor DSA had any effect on the PPARa mRNA levels.
Nutritionists may recommend increased consumption of c9,
t11-CLA and long-chain PUFA. The production costs of pure
c9, t11-CLA supplements are prohibitive, therefore naturally
enriched CLA meat and dairy products, containing c9, t11-
CLA and its precursor TVA, could become a good alternative
to fatty acid supplementation (Corl et al. 2003). The research
presented here in relation to the intestinal desaturation of TVA
is highly relevant within the context of any potential health
benefits of food sources of TVA and CLA. The results suggest
that EPA could decrease the positive effects of TVA, by
inhibiting its intestinal desaturation, illustrating once again
the potential interactions between nutrients at the intestinal
level.
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